Vest Financial LLC grew its position in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 88.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 54,538 shares of the electronics maker’s stock after purchasing an additional 25,596 shares during the period. Vest Financial LLC’s holdings in Dolby Laboratories were worth $3,947,000 at the end of the most recent reporting period.
Several other institutional investors have also recently modified their holdings of DLB. State Street Corp lifted its position in Dolby Laboratories by 8.7% in the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock worth $167,906,000 after buying an additional 180,072 shares during the last quarter. AQR Capital Management LLC raised its stake in shares of Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after acquiring an additional 592,282 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Dolby Laboratories by 2.0% in the 2nd quarter. Geode Capital Management LLC now owns 1,556,571 shares of the electronics maker’s stock worth $116,159,000 after acquiring an additional 30,057 shares during the last quarter. Frontier Capital Management Co. LLC lifted its holdings in shares of Dolby Laboratories by 2.3% in the 2nd quarter. Frontier Capital Management Co. LLC now owns 1,237,667 shares of the electronics maker’s stock worth $91,909,000 after acquiring an additional 28,243 shares during the last quarter. Finally, First Trust Advisors LP boosted its stake in shares of Dolby Laboratories by 35.2% in the 2nd quarter. First Trust Advisors LP now owns 1,237,443 shares of the electronics maker’s stock valued at $91,893,000 after purchasing an additional 322,063 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of equities analysts recently commented on DLB shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 29th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Monday, January 5th. Barrington Research reduced their price objective on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 19th. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Thursday. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $92.00.
Dolby Laboratories Stock Performance
Shares of DLB stock opened at $62.66 on Friday. Dolby Laboratories has a fifty-two week low of $61.33 and a fifty-two week high of $89.66. The firm has a market cap of $5.98 billion, a P/E ratio of 23.83 and a beta of 0.88. The business’s 50 day moving average price is $65.47 and its 200-day moving average price is $69.42.
Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. The company had revenue of $307.02 million during the quarter, compared to analyst estimates of $305.76 million. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The firm’s revenue was up .7% on a year-over-year basis. During the same quarter last year, the firm posted $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, equities analysts predict that Dolby Laboratories will post 2.94 EPS for the current year.
Dolby Laboratories Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were given a dividend of $0.36 per share. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Tuesday, December 2nd. Dolby Laboratories’s payout ratio is 54.75%.
Insider Buying and Selling at Dolby Laboratories
In related news, CEO Kevin J. Yeaman sold 6,751 shares of the company’s stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $67.24, for a total value of $453,937.24. Following the sale, the chief executive officer owned 98,377 shares in the company, valued at $6,614,869.48. This represents a 6.42% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Mark Andrew Sherman sold 2,491 shares of the company’s stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $67.26, for a total transaction of $167,544.66. Following the transaction, the executive vice president owned 70,563 shares in the company, valued at $4,746,067.38. This represents a 3.41% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 137,120 shares of company stock worth $9,184,809. Insiders own 37.93% of the company’s stock.
Dolby Laboratories Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- The $100 Trillion AI Story No One Is Telling You
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
